A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.

Hatano, Hiroyu; Hayes, Timothy L; Dahl, Viktor; Sinclair, Elizabeth; Lee, Tzong-Hae; Hoh, Rebecca; Lampiris, Harry; Hunt, Peter W; Palmer, Sarah; McCune, Joseph M; Martin, Jeffrey N; Busch, Michael P; Shacklett, Barbara L; Deeks, Steven G

Hatano, Hiroyu; Hayes, Timothy L; Dahl, Viktor; Sinclair, Elizabeth; Lee, Tzong-Hae; Hoh, Rebecca; Lampiris, Harry; Hunt, Peter W; Palmer, Sarah; McCune, Joseph M; Martin, Jeffrey N; Busch, Michael P; Shacklett, Barbara L; Deeks, Steven G.

Affiliation

Hatano H; University of California, San Francisco, USA. hhatano@php.ucsf.edu

J Infect Dis ; 203(7): 960-8, 2011 Apr 01.

Article in En | MEDLINE | ID: mdl-21402547

Subject(s)

Anti-HIV Agents/administration & dosage; CD4-Positive T-Lymphocytes/immunology; HIV Infections/drug therapy; Pyrrolidinones/administration & dosage; ADP-ribosyl Cyclase 1/analysis; Anti-HIV Agents/adverse effects; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes/chemistry; CD8-Positive T-Lymphocytes/immunology; HLA-DR Antigens/analysis; Humans; Membrane Glycoproteins/analysis; Placebos/administration & dosage; Pyrrolidinones/adverse effects; Raltegravir Potassium; T-Lymphocyte Subsets/immunology; Treatment Outcome; Viral Load; Viremia

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrrolidinones / CD4-Positive T-Lymphocytes / HIV Infections / Anti-HIV Agents Type of study: Clinical_trials Limits: Humans Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google